Drug Topics

MAY 16, 2023

The National Community Pharmacists Association now has plenty of allies in its fight with the pharmacy benefit managers.

469

469

PhRMA

MAY 16, 2023

Enhancing clinical trial diversity is a challenge, but with a multi-faceted, community-centered approach, we can help underrepresented patients be more involved in the research and development of potential life-saving medical treatments.

159

159

Drug Topics

MAY 16, 2023

Adam Fein, Ph.D., talked about some surprising trends in specialty pharmacy and healthcare at the 2023 Asembia Specialty Pharmacy Summit. The number of specialty pharmacy locations may be peaking. And that "gross-to-net bubble" in drug prices that Fein has written about so much — well, it may be shrinking.

Specialty Pharmacies 247

Specialty Pharmacies 247

Fierce Healthcare

MAY 16, 2023

Kaiser Permanente discloses timeline, financial commitments for its VBC megadeal with Geisinger Health dmuoio Tue, 05/16/2023 - 12:40

138

138

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

MAY 16, 2023

Ms Maroney drives a conversation regarding response to treatment-resistant depression.

247

247

PharmaVoice

MAY 16, 2023

SAb Biotherapeutics is working on a novel product that uses cow antibodies genetically engineered into human antibodies to prevent and treat infectious diseases.

130

130

PharmaVoice

MAY 16, 2023

The European Union published a long-awaited proposal that could bring sweeping changes to its pharma sector last month, but the legislative fight has only just begun.

130

130

Fierce Healthcare

MAY 16, 2023

UnitedHealthcare defends controversial prior authorization policy for colonoscopies fdiamond Tue, 05/16/2023 - 16:43

128

128

Pharmacy Times

MAY 16, 2023

Health care professionals should educate patients that it is possible to effectively manage pain without opioids.

123

123

Fierce Pharma

MAY 16, 2023

FTC seeks to block Amgen's $28B Horizon buy in 'broadly negative' move for biopharma M&A: report aliu Tue, 05/16/2023 - 09:41

117

117

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

MAY 16, 2023

Teva is unable to meet demand for dextroamphetamine/amphetamine, and other companies struggle to keep up.

123

123

Fierce Healthcare

MAY 16, 2023

Legislators reintroduce bill aimed at easing barriers to virtual mental health care in Medicare pminemyer Tue, 05/16/2023 - 16:38

116

116

Pharmacy Times

MAY 16, 2023

Since the 2018 guideline’s publication, additional non-statin therapies such as bempedoic acid, evinacumab, and inclisiran, have been approved by the FDA for the management of hypercholesterolemia.

FDA 123

FDA 123

Fierce Healthcare

MAY 16, 2023

New startup aims to build generative AI for healthcare armed with $50M from General Catalyst, A16z hlandi Tue, 05/16/2023 - 08:37

112

112

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

MAY 16, 2023

Skinvive by Juvéderm is a first of its kind medication to create skin smoothness that lasts 6 months with optimal treatment.

FDA 121

FDA 121

Drug Store News

MAY 16, 2023

Traditional drug store retailers seek to become one-stop healthcare destinations amid competition from online players and others.

111

111

Pharmacy Times

MAY 16, 2023

Low compensation, stressful environment spark technician exodus; replacing them has been difficult.

120

120

Drug Store News

MAY 16, 2023

CVS Health is enhancing Project Health, the company's free, community-based health screening program.

111

111

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Pharma

MAY 16, 2023

It's the end of the line for J&J's COVID shot in the US, CDC says fkansteiner Tue, 05/16/2023 - 14:32

111

111

STAT

MAY 16, 2023

During an extraordinary hearing Tuesday, members of a Senate subcommittee called for aggressive regulation of generative AI tools — and the makers and users of the technologies themselves urged the senators to quickly follow through. “Regulatory intervention by governments will be critical to mitigate the risks of increasingly powerful models,” said Sam Altman, the CEO of OpenAI, the company behind ChatGPT.

FDA 106

FDA 106

Fierce Pharma

MAY 16, 2023

AstraZeneca follows AbbVie, Teva in surprising departure from lobbying group PhRMA zbecker Tue, 05/16/2023 - 11:06

109

109

Drug Store News

MAY 16, 2023

Two new mobile kitchens will travel to the West Coast and Midwest during Military Appreciation Month.

106

106

STAT

MAY 16, 2023

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences.  Sign up to get this newsletter  delivered in your inbox every Tuesday and Thursday.

105

105

Drug Store News

MAY 16, 2023

Today’s consumers have many choices when it comes to over-the-counter eye care and ear care products.

105

105

European Pharmaceutical Review

MAY 16, 2023

So far, 2023 has seen several major developments in stem cell-based therapies. Stem cells have the ability to self-renew. Their potential to differentiate into cells of different tissues makes them particularly interesting for applications in regenerative medicine. 1 Since the first therapy using stem cells was developed in 1957, only few stem cell-based therapies have entered the clinic 1 as advanced therapy medicinal products (ATMPs).

Hospitals 104

Hospitals 104

Pharmaceutical Technology

MAY 16, 2023

CHARM Therapeutics has received investment from NVIDIA’s venture investment arm, NVentures, for deep learning-enabled drug discovery research. Representing a major milestone for the company, the investment will enable CHARM to do further work on the research and development of new medicines for oncology. It will also allow the company to continue to fund its growing organisation while utilising the accelerated computing platform of NVIDIA.

Compounding 103

Compounding Communication 103

STAT

MAY 16, 2023

WASHINGTON — AstraZeneca has decided to leave the brand drug lobbying powerhouse PhRMA halfway through the year, the organization said. The exit is the group’s third in five months, as AbbVie exited PhRMA in December and Teva Pharmaceuticals left in February.

101

101

Pharma Tutor

MAY 16, 2023

Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) : Making Quality Medicines Affordable and Accessible in India admin Tue, 05/16/2023 - 15:25 About Author Ramraj Choudhary M.Pharma, (Pharmaceutics) Dr. H.S Gour University, Sagar MP Current Position : Sr.

98

98

STAT

MAY 16, 2023

Advancement in the science of eye care over the past 10 years has led to dramatically better outcomes for many people with impaired vision. Take anti-VEGF medications for wet age-related macular degeneration (AMD) for example. Anti-VEGFs, which are injected into the eye, slow the growth of blood vessels that often lead to wet AMD, one of the leading causes of blindness in the world.

101

101

Fierce Healthcare

MAY 16, 2023

Federal appeals court grants stay in ACA preventive care ruling pminemyer Tue, 05/16/2023 - 11:58

98

98

STAT

MAY 16, 2023

A chain of luxury ketamine clinics called Field Trip started churning through business strategies at an increasingly rapid pace late last year. The money was running out, clinics were half full, and the company’s vice president of clinical services was under intense pressure to launch an at-home ketamine service. It was a challenging assignment, figuring out how to safely provide a sedative to depressed patients away from clinic supervision, but Elizabeth Wolfson said senior leaders gave

98

98

ISPE

MAY 16, 2023

ISPE GAMP® Blockchain Special Interest Group Trudy Patterson Tue, 05/16/2023 - 10:24 iSpeak Blog iSpeak ISPE GAMP® Blockchain Special Interest Group James Canterbury Tanya Sharma 16 May 2023 The ISPE GAMP ® Blockchain Special Interest Group is excited to be in its 4th year! For those of you following this space I’m sure you can appreciate the roller coaster of events across crypto, blockchain, and pharma over that time.

Compounding 98

Compounding 98

STAT

MAY 16, 2023

An experimental RSV vaccine developed by Pfizer to protect infants — by vaccinating pregnant people — was shown to be effective in preventing severe lower respiratory tract disease, the Food and Drug Administration said Tuesday in an analysis of the data generated to support licensure of the vaccine. The agency’s analysis said the vaccine was also shown to be effective at preventing non-severe lower respiratory tract RSV disease that required medical attention at 180 days af

Vaccines 98

Vaccines Documentation FDA 98